ACS Omega
(Oct 2024)
ML385, an Nrf2 Inhibitor, Synergically Enhanced Celastrol Triggered Endoplasmic Reticulum Stress in Lung Cancer Cells
- Chenxin Xu,
- Yinghua Chen,
- Zhuoen Zhou,
- Ying Yan,
- Wenying Fu,
- Peng Zou,
- Daoyong Ni
Affiliations
- Chenxin Xu
- Affiliated Yueqing Hospital, Wenzhou Medical University, Wenzhou, China
- Yinghua Chen
- School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, China
- Zhuoen Zhou
- School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, China
- Ying Yan
- School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, China
- Wenying Fu
- School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, China
- Peng Zou
- Affiliated Yueqing Hospital, Wenzhou Medical University, Wenzhou, China
- Daoyong Ni
- Affiliated Yueqing Hospital, Wenzhou Medical University, Wenzhou, China
- DOI
-
https://doi.org/10.1021/acsomega.4c06152
- Journal volume & issue
-
Vol. 9,
no. 43
pp.
43697
– 43705
WeChat QR code
